InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: amarininvestor post# 237289

Thursday, 12/26/2019 9:12:55 PM

Thursday, December 26, 2019 9:12:55 PM

Post# of 426749
a-

A settlement would be best for all parties, but the lawyer noted recent developments with one party cut against the possibility of settling...The lawyer concurred with our view a settlement would be in the best interest of Amarin, Dr. Reddy's and Hikma. Moreover, highlighted in the low probability Dr. Reddy's or Hikma win the case, it would allow 5+ generics to enter the market while it is still immature, which would not be ideal for the any party - again incentivizing all parties to settle. However, the lawyer noted Dr. Reddy's has shown a proclivity not to settle over the past 18 months or so. This is in line with conversations with Dr. Reddy's mgmt who has suggested they are not willing to settle. So this remains an issue and it's possible AMRN may have to litigate this to a decision - although the expert feels very confident AMRN will prevail.

Best,
G

"There are some things money can't buy. … For these, there is AMRN."

Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News